{"id":"W2282455907","doi":"10.1177/2048872616633880","title":"Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial","year":2016,"lang":"en","type":"article","venue":"European Heart Journal Acute Cardiovascular Care","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Janssen Research and Development; Servier; Regado Biosciences; Medicines Company; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Stanford Bio-X; MyoKardia; Gilead Sciences; GlaxoSmithKline; Amgen; Pfizer; Sanofi; American Heart Association","keywords":"Thienopyridine; Medicine; Acute coronary syndrome; Cardiology; Internal medicine; Myocardial infarction; Clinical endpoint; Stroke (engine); Clopidogrel; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003391873,0.0003609121,0.001068577,0.0001784075,0.0001854426,0.0009414034,0.0003678835,0.0009012204,0.001176768],"category_scores_gemma":[0.005411495,0.0002412356,0.0009864019,0.0004724228,0.0006648825,0.0006599095,0.0002660808,0.001005996,0.0001367256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000399058,"about_ca_system_score_gemma":0.0004562735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000851904,"about_ca_topic_score_gemma":0.001625744,"domain_scores_codex":[0.9986884,0.0008677242,0.00009352881,0.0001335215,0.0001216228,0.00009515056],"domain_scores_gemma":[0.9955966,0.002185131,0.00122257,0.000361461,0.0001498275,0.0004845391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5179252,0.001816415,0.4163207,0.001077085,0.007448295,0.0006578327,0.0004637108,0.001172563,0.006293502,0.001493386,0.001554316,0.04377708],"study_design_scores_gemma":[0.07374282,0.05087539,0.8538303,0.0003254563,0.00749199,0.001295076,0.0003229813,0.003876306,0.001159477,0.001886705,0.00504003,0.0001535109],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916852,0.00671482,0.000190916,0.0002434721,0.0000388605,0.00004806702,0.0002399803,0.000005948981,0.0008327321],"genre_scores_gemma":[0.9975514,0.001339018,0.0001575095,0.0001521563,0.00009503651,0.0000270495,0.000490988,0.000002718212,0.0001841973],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003391873,"threshold_uncertainty_score":0.0179382,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02589130734681251,"score_gpt":0.2723322871805499,"score_spread":0.2464409798337374,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}